- জেনেরিক নাম
- Glimepiride
- শক্তি
- 1 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Advanced Chemical Industries PLC
৳ ৫.৮৮ ৳ ৬.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
বাংলাদেশে Glimirid 1 mg Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Glimepiride আছে (১ mg)। তালিকাভুক্ত প্রতি ইউনিটের দাম ৬ টাকা। Glimirid-এর সাথে Glimepiride-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এটি তৈরি করে Advanced Chemical Industries PLC। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Glimepiride-এর ৪১টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ১০টি। সবচেয়ে কম দাম Mepid 1 mg Tablet-এর, প্রতি ইউনিট ৳ ২.৫১।
Made by Advanced Chemical Industries PLC, Glimirid is a tablet whose active ingredient is Glimepiride. It contains Glimepiride, which belongs to the sulfonylurea group of antidiabetic medicines. It may also be combined with metformin in some patients. The dose and course are set by your doctor based on your blood sugar levels.
It may also be used together with metformin when diet, exercise and either medicine alone do not give adequate control. It is not for type I diabetes, diabetic ketoacidosis, or diabetic coma. It is prescribed when diet and exercise alone are not enough to keep blood sugar under control. The doctor decides whether it suits a particular person.
Swallow the tablet with water; you can take it with or without food, but follow your doctor's advice. Glimirid is taken by mouth. Take Glimirid exactly as your doctor tells you. The doctor decides the dose and the course, and adjusts them based on regular blood and urine sugar checks. Your doctor will check your blood sugar regularly and may adjust the dose.
Low blood sugar (hypoglycaemia) is the main side effect to watch for, along with temporary blurred vision, nausea, vomiting, diarrhoea, abdominal pain, skin rash (urticaria) and a fall in blood pressure. The most common is low blood sugar (hypoglycaemia). Contact your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
It is not to be taken during pregnancy or while breastfeeding; insulin is needed instead. It must not be taken while breastfeeding, as it may harm the child, so breastfeeding may need to be stopped or changed. In the first weeks of treatment the risk of low blood sugar may be higher, so monitoring matters. Ask your doctor first if any of these apply to you.
It may also be used together with metformin when diet, exercise and either medicine alone do not give adequate control. It is not for type I diabetes, diabetic ketoacidosis, or diabetic coma.
Swallow the tablet with water; you can take it with or without food, but follow your doctor's advice. Glimirid is taken by mouth.
Low blood sugar (hypoglycaemia) is the main side effect to watch for, along with temporary blurred vision, nausea, vomiting, diarrhoea, abdominal pain, skin rash (urticaria) and a fall in blood pressure. The most common is low blood sugar (hypoglycaemia).
The listed price is ৳ ৬.০০.
৳ ৫.৮৮ ৳ ৬.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is indicated in following conditions-এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is a sulfonylurea antidiabetic agent which decreases blood glucose concentration. The primary mechanism of action of Glimepiride appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. Glimepiride acts in concert with glucose by improving the sensitivity of beta cells to physiological glucose stimulus, resulting in insulin secretion. In addition, extrapancreatic effects like reduction of basal hepatic glucose production, increased peripheral tissue sensitivity to insulin and glucose uptake may also play role in the activity of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic action of a single dose of Glimepiride persists for 24 hours.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In principle, the dosage of Glimepiride is governed by the desired blood sugar level. The dosage of Glimepiride must be the lowest which is sufficient to achieve the desired metabolic control. The initial and the maintenance doses are set based on the results of regular check of glucose in blood and urine. Monitoring of glucose levels in blood and urine also serves to detect either primary or secondary failure of therapy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Based on experience with Glimepiride and known interactions for other sulfonylureas, the following interactions must be considered.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is not suitable for the treatment of insulin dependent (type I) diabetes mellitus, or for the treatment of diabetic ketoacidosis, nor for the treatment of diabetic coma. Glimepiride must not be used in patients hypersensitive to Glimepiride, other sulfonylureas, other sulfonamides, severe hepatic dysfunction, severe impairment of renal function and dialysis patients.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypoglycaemia, temporary visual impairment, nausea, vomiting, diarrhoea, abdominal pain, urticaria, fall in blood pressure.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride must not be taken during pregnancy; a changeover to insulin is necessary. Patients planning a pregnancy must inform their physician, and should change over to insulin. Ingestion of Glimepiride with breast milk feeding may harm the child. Therefore, Glimepiride must not be taken by breastfeeding women. Either a changeover or complete discontinuation of breastfeeding is necessary.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
in the initial weeks of treatment, the risk of hypoglycaemia may be increased and necessitates careful monitoring. If such risk present it may be necessary to adjust the dosage of Glimepiride, Hypoglycaemia can almost be promptly controlled by immediate intake of carbohydrates (glucose or sugar).এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Overdosage of sulfonylureas, including Glimepiride, can produce hypoglycaemia. Mild hypoglycaemic symptoms without loss of consciousness or neurologic findings should be treated aggressively with oral glucose and adjustments in drug dosage or meal patterns. Close monitoring should continue until the physician is assured that the patient is out of danger. Severe hypoglycaemic reactions with coma, seizure, or other neurological impairment occur infrequently, but constitute medicai emergencies requiring immediate hospitalization. If hypoglycaemic coma is diagnosed or suspected, the patient should be given a rapid intravenous injection of concentrated (50%) glucose solution. This should be followed by a continuous infusion of a more dilute (10%) glucose solution at a rate that will maintain the blood glucose at a level above 100 mg/dl. Patients should be closely monitored for a minimum of 24 to 48 hours, because hypoglycaemia may recur after apparent clinical recovery.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Do not store above 30°C. Keep away from light and out of the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।